MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fmed.2026.1711751

Медицинская библиотека · Frontiers in medicine · 2026

Diminished plasma levels of GPIb-α predict mortality in a prospective ARDS cohort.

Bernard Alice, Serna-Higuita Lina Maria, Althaus Karina, Rosenberger Peter, Vöhringer Robin, Körner Andreas, Haeberle Helene, Eggstein Claudia, Bakchoul Tamam, Margraf Andreas, Fodi Christina, Zarbock Alexander, Koeppen Michael, Mirakaj Valbona

Клиническое исследованиеСтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Activated immune cells can interact with platelets and trigger the coagulation cascade in response to inflammatory stimuli, resulting in the formation of microthrombi which help contain the spread of pathogens, but also contribute to organ dysfunction. Platelet glycoprotein receptor GPIb-α binds to von Willebrand factor and mediates cross-linking of platelets and thrombosis. In the multicenter Thilo trial, we measured plasma levels of GPIb-α to correlate our measurements with the clinical presentation of ARDS.

METHODS

GPIb-α plasma levels were measured on the first 5 days after study inclusion in 125 ARDS patients. Plasma levels of GPIb-α of survivors and non-survivors were compared; additionally, we issued a receiver operating characteristics (ROC) curve of GPIb-α levels and performed a survival analysis of patients stratified by their GPIb-α plasma levels. Multivariate Cox analysis was performed to identify risk factors for mortality.

RESULTS

Cox analysis showed that low GPIb-α levels were associated with higher mortality. In survivors, GPIb-α levels were significantly higher than in non-survivors. ROC analysis revealed an AUC value of 0.73 for the biomarker. For the Kaplan-Meier curve, patients with the lowest GPIb-α levels (0-130 ng/mL) had a mortality rate of 53%; in patients with higher levels (341-850 ng/mL), the mortality rate was 10%.

DISCUSSION: We are the first to report a role for platelet GPIb-α as a potential biomarker in ARDS. Lower GPIb-α plasma levels were associated with a higher mortality rate in ARDS. Diminished plasma levels might point to a higher consumption of the receptor, with an unfavorable effect on overall survival.

TRIAL REGISTRATION: EUDRA-CT: 2016-003168-37. Registered on 12/04/2017. ClinicalTrials.gov: NCT03111212. Registered on 04/06/2017.

Для цитирования: Bernard Alice, Serna-Higuita Lina Maria, Althaus Karina, Rosenberger Peter, Vöhringer Robin, Körner Andreas, Haeberle Helene, Eggstein Claudia, Bakchoul Tamam, Margraf Andreas, Fodi Christina, Zarbock Alexander, Koeppen Michael, Mirakaj Valbona. Diminished plasma levels of GPIb-α predict mortality in a prospective ARDS cohort.. Frontiers in medicine. 2026. DOI: 10.3389/fmed.2026.1711751.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.